IANNOTTA, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 1.224
EU - Europa 354
AS - Asia 283
SA - Sud America 2
Totale 1.863
Nazione #
US - Stati Uniti d'America 1.224
CN - Cina 186
UA - Ucraina 99
DE - Germania 93
TR - Turchia 73
GB - Regno Unito 44
SE - Svezia 32
IT - Italia 31
FI - Finlandia 23
SG - Singapore 20
RU - Federazione Russa 12
NL - Olanda 11
BE - Belgio 3
FR - Francia 3
CZ - Repubblica Ceca 2
IN - India 2
BD - Bangladesh 1
BO - Bolivia 1
BR - Brasile 1
IE - Irlanda 1
TW - Taiwan 1
Totale 1.863
Città #
Woodbridge 184
Chandler 143
Fairfield 120
Jacksonville 111
Ann Arbor 99
Houston 90
Nanjing 50
Ashburn 49
Wilmington 47
Beijing 45
Seattle 44
Izmir 40
Cambridge 36
Princeton 28
Bremen 21
Milan 21
Boardman 20
Addison 16
Shanghai 16
New York 14
Nanchang 11
Hebei 10
San Diego 10
Meppel 9
Singapore 9
Auburn Hills 8
Redmond 7
Shenyang 7
Tianjin 7
Changsha 6
Dearborn 6
San Mateo 6
Kunming 5
Philadelphia 5
Hefei 4
Jiaxing 4
Jinan 4
Brussels 3
Chicago 3
Falls Church 3
Norwalk 3
Orange 3
Zhengzhou 3
Des Moines 2
Fuzhou 2
Hangzhou 2
Lanzhou 2
Mountain View 2
Pune 2
Verona 2
Americana 1
Amsterdam 1
Augusta 1
Bologna 1
Brno 1
Changchun 1
Dublin 1
Edinburgh 1
Fort Lauderdale 1
Guangzhou 1
Haikou 1
Helsinki 1
Jülich 1
London 1
Los Angeles 1
Moscow 1
Ningbo 1
Sucre 1
Taipei 1
Taiyuan 1
Taizhou 1
Wuhan 1
Zhongxin 1
Totale 1.367
Nome #
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 117
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 112
New potent and selective human adenosine A3 receptor antagonists. 112
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 106
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 103
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 102
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 101
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 97
New potent and selective human adenosine A3 receptor antagonists 93
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 90
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 83
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 72
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 71
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 69
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 67
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 65
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 65
Expression and functional A3 adenosine receptors in human lymphocytes 64
Effects of doxazosin and propranolol on A2A adenosine receptos of essential hypertensive patients 62
Pharmacological and biochemical characterization of A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells. 61
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A(1) receptor 54
Totale 1.875
Categoria #
all - tutte 6.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020397 78 11 9 49 21 45 29 38 30 41 41 5
2020/2021191 27 18 4 25 3 24 2 28 2 24 27 7
2021/2022220 6 17 15 6 3 9 5 4 6 20 26 103
2022/2023323 25 41 10 50 61 31 23 22 37 0 16 7
2023/202499 11 12 1 0 6 21 4 4 5 0 12 23
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.875